The Role of the Spleen in Portal Hypertension.
暂无分享,去创建一个
J. Ueda | H. Yoshida | Y. Mamada | N. Taniai | M. Yoshioka | Y. Kawano | A. Matsushita | T. Shimizu | Mampei Kawashima
[1] P. Galle,et al. Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy , 2022, Cancers.
[2] P. Vishnyakova,et al. Spleen: Reparative Regeneration and Influence on Liver , 2022, Life.
[3] C. Menias,et al. Abdominal and pelvic splenosis: atypical findings, pitfalls, and mimics , 2022, Abdominal Radiology.
[4] J. Akatsuka,et al. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma , 2021, BMC Urology.
[5] H. Yoshida,et al. Management of portal hypertension based on portal hemodynamics , 2021, Hepatology research : the official journal of the Japan Society of Hepatology.
[6] S. Lewis,et al. Structure and function of the immune system in the spleen , 2019, Science Immunology.
[7] J. García‐Pagán,et al. Idiopathic Portal Hypertension , 2018, Hepatology.
[8] M. McConnell,et al. Biology of portal hypertension , 2017, Hepatology International.
[9] Zong-fang Li,et al. The spleen in liver cirrhosis: revisiting an old enemy with novel targets , 2017, Journal of Translational Medicine.
[10] A. Sauvanet,et al. Medical complications following splenectomy. , 2016, Journal of visceral surgery.
[11] O. Yokosuka,et al. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis. , 2015, World journal of gastroenterology.
[12] R. Groszmann,et al. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. , 2015, Journal of hepatology.
[13] Prabhu Dayal Sinwar,et al. Overwhelming post splenectomy infection syndrome - review study. , 2014, International journal of surgery.
[14] T. Utsunomiya,et al. Cytokine expression in spleen affects progression of liver cirrhosis through liver–spleen cross‐talk , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.
[15] G. Casazza,et al. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. , 2014, Journal of hepatology.
[16] R. Hoover,et al. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up , 2014, Haematologica.
[17] G. Tarantino,et al. Liver-spleen axis: intersection between immunity, infections and metabolism. , 2013, World journal of gastroenterology.
[18] Tomomi Yamada,et al. Dual cytoprotective effects of splenectomy for small‐for‐size liver transplantation in rats , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] Wei Wei,et al. Enhanced liver regeneration in IL-10-deficient mice after partial hepatectomy via stimulating inflammatory response and activating hepatocyte STAT3. , 2011, The American journal of pathology.
[20] C. Hellerbrand,et al. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction , 2011, Gut.
[21] M. Mejías,et al. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension. , 2010, Journal of hepatology.
[22] M. Hashizume,et al. GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION) , 2010, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[23] E. Uchida,et al. Successful management of a symptomatic splenic artery aneurysm with transcatheter embolization. , 2009, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[24] M. Manns,et al. Thrombocytopenia associated with chronic liver disease. , 2008, Journal of hepatology.
[25] A. Gatta,et al. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis. , 2008, Molecular aspects of medicine.
[26] M. Mejías,et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet‐derived growth factor blockade in rats , 2007, Hepatology.
[27] S. Choi,et al. Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. , 2006, American journal of surgery.
[28] R. Groszmann,et al. The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule , 2006, Hepatology.
[29] Y. Mizuguchi,et al. Long-Term Results of Partial Splenic Artery Embolization as Supplemental Treatment for Portal-Systemic Encephalopathy , 2005, The American Journal of Gastroenterology.
[30] Y. Mizuguchi,et al. Splenic artery embolization before laparoscopic splenectomy in children , 2005, Surgical Endoscopy And Other Interventional Techniques.
[31] Y. Mizuguchi,et al. Hand-assisted laparoscopic hepatectomy after partial splenic embolization , 2003, Surgical Endoscopy And Other Interventional Techniques.
[32] L. Bolondi,et al. Influence of the Spleen on Portal Haemodynamics: a Non-invasive Study with Doppler Ultrasound in Chronic Liver Disease and Haematological Disorders , 2002, Scandinavian journal of gastroenterology.
[33] K. Sharkey,et al. Hyperdynamic circulation in portal‐hypertensive rats is dependent on central c‐fos gene expression , 2002, Hepatology.
[34] M. Hashizume,et al. Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor β‐1 , 2002, Journal of gastroenterology and hepatology.
[35] M. Valgimigli,et al. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: A long‐term prospective study , 1999, Hepatology.
[36] Fabio Piscaglia,et al. Superior mesenteric artery impedance in chronic liver diseases: relationship with disease severity and portal circulation , 1998, American Journal of Gastroenterology.
[37] R. Stauber,et al. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats , 1998, Hepatology.
[38] P. Angeli,et al. Splenic impedance indices: A useful method to monitor patients after liver transplantation? , 1998, Hepatology.
[39] T. Gupta,et al. Pathophysiology of portal hypertension. , 1997, Clinics in liver disease.
[40] T. Tajiri,et al. Hepatic lobar differences in progression of chronic liver disease: Correlation of asialoglycoprotein scintigraphy and hepatic functional reserve , 1997, Hepatology.
[41] M. Halliwell,et al. Splanchnic blood flow in patients with cirrhosis and portal hypertension: investigation with duplex Doppler US. , 1995, Radiology.
[42] J. Utsunomiya,et al. The effect of splenomegaly on splanchnic hemodynamics in nonalcoholic cirrhosis after distal splenorenal shunt and splenopancreatic disconnection , 1994, Hepatology.
[43] F. Moriyasu,et al. Distribution of mesenteric and splenic blood flow in cirrhosis of the liver as estimated by radionuclide angiography. , 1993, Internal medicine.
[44] R. Gibson,et al. Duplex Doppler ultrasound signs of portal hypertension: relative diagnostic value of examination of paraumbilical vein, portal vein and spleen. , 1992, Australasian radiology.
[45] R. Gibson,et al. Splenomegaly--an insensitive sign of portal hypertension. , 1990, Australian and New Zealand journal of medicine.
[46] S. Todo,et al. Reversal of hypersplenism following orthotopic liver transplantation. , 1989, Annals of surgery.
[47] A. Ferrante,et al. Alterations in function and subpopulations of peripheral blood mononuclear leukocytes in children with portal hypertension. Leukocyte subtypes and function in portal hypertension. , 1989, International archives of allergy and applied immunology.
[48] D. Granger,et al. "Forward" and "backward" flow mechanisms of portal hypertension. Relative contributions in the rat model of portal vein stenosis. , 1985, Gastroenterology.
[49] R. Williams,et al. Injection studies of the splenic vasculature in portal hypertension. , 1966, Gut.